Articles published by Purple Biotech Ltd.
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
March 14, 2024
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial
February 13, 2024
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Reaches Recommended Phase 2 Dose for NT219
February 01, 2024
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors
December 20, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Fortifies NT219 Patent Protection
November 02, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Announces $5 Million Registered Direct Offering
October 17, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech to Present New CM24 Pancreatic Cancer Biomarker Data at AACR Special Conference on September 28, 2023
September 21, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Reports Second Quarter 2023 Financial Results
August 22, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Debuts Scientific Advisory Board
April 25, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual Conference
April 18, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Announces First Patient Dosed in Open Label, Randomized Part of CM24 Phase 2 Clinical Trial
February 14, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis
November 15, 2022
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech to Present at the Jefferies London Healthcare Conference
November 10, 2022
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Purple Biotech Appoints Lior Fhima as Chief Financial Officer
November 02, 2022
From Purple Biotech Ltd.
Via GlobeNewswire
Tickers
PPBT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.